News

Olema Oncology Unveils Participation in Key Investor Conferences

Olema Oncology Unveils Participation in Key Investor Conferences

Olema Oncology Announces Upcoming Investor Conferences

Olema Pharmaceuticals, Inc. ("Olema", or "Olema Oncology", NASDAQ: OLMA), a pioneering clinical-stage biopharmaceutical company specializing in breast cancer therapies, is gearing up for several significant investor conferences. This is a noteworthy period as the company shares insights and strategies with stakeholders.

Highlights of the Investor Conferences

As part of its engagement strategy, Olema will appear at the following prominent conferences:

Guggenheim 2nd Annual Healthcare Innovation Conference

The conference is set for November 10 at 10:30 a.m. ET. Olema's participation will occur in a fireside chat format, providing a platform for discussion and insight exchange.

UBS Global Healthcare Conference 2025

On November 12 at 8:00 a.m. ET, Olema will participate in a presentation format at this crucial healthcare conference, emphasizing their commitment to innovation.

Jefferies London Healthcare Conference 2025

This influential conference will take place on November 19 at 9:00 a.m. GMT / 4:00 a.m. ET, where Olema will again engage in a fireside chat to share their advancements and plans.

Webcasts and Presentation Recaps

Live webcasts of these conferences will be available for viewing on Olema's investor relations website. Potential investors and interested stakeholders can visit the site to access live coverage and recorded sessions from these events.

Core Mission and Vision of Olema Oncology

Olema Oncology is on a mission to redefine standards of care for patients with advanced breast cancer. Their innovative approach is reflected in their drug development, focusing on the discovery and commercialization of targeted therapies. The lead candidate, palazestrant (OP-1250), showcases Olema's dedication to advancing breast cancer treatment. This drug is a complete estrogen receptor antagonist and is currently involved in two pivotal Phase 3 trials.

Insights into Product Pipeline

The company's research doesn't stop with palazestrant. Olema is also exploring OP-3136, a potent KAT6 inhibitor currently in Phase 1 clinical studies. This innovative product pipeline underlines Olema's commitment to tackling breast cancer through diverse therapeutic options.

Company Background

Based in San Francisco, Olema is not just about developing drugs; it’s about making a significant impact on the lives of patients. Their deep understanding of cancer biology, particularly in the context of endocrine-driven cancers, equips them to confront challenges in treatment head-on.

Contact Information for Media Inquiries

For further inquiries, Courtney O'Konek, Vice President of Corporate Communications, is available at media@olema.com. She serves as the primary contact for any media or investor-related questions.

Frequently Asked Questions

What conferences will Olema Oncology participate in?

Olema Oncology will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference, the UBS Global Healthcare Conference, and the Jefferies London Healthcare Conference.

When are the upcoming investor conferences?

The conferences are set for November 10, November 12, and November 19, 2025, at various times.

What is Olema Oncology’s primary focus?

Olema Oncology mainly focuses on discovering and developing targeted therapies for breast cancer and aims to transform patient outcomes.

Where can I find webcasts of the conferences?

Webcasts will be available in the Events and Presentations section of Olema's investor relations website.

Who should I contact for media inquiries?

You can reach Courtney O'Konek at media@olema.com for any media inquiries regarding Olema Oncology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 114

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 108

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 92

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 207

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Stephanie L. Beiermann Shines in HR Consulting Honors

Updated Category News Views 37

Celebrating a Star in Payroll Optimization Ah, the name Stephanie L. Beiermann’s been making the rounds lately, catching eyes with her lauded expertise in payroll optimization and human resources. This recognition doesn’t come out of thin air—no, it’s anchored on a solid foundation of over 25 years of cutting through the fluff to sharpen operational edges. We’re...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 27

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 159

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 52

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 95

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 93

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading

Top 5 Most Recently Viewed Articles

Trustmark Corporation Schedules Fourth Quarter Earnings Call

Updated Category News Views 204

Trustmark Corporation Plans Q4 Financial Results Announcement Trustmark Corporation (NASDAQGS:TRMK) is set to announce its fourth quarter financial results soon. The announcement will take place through a news release after the market closes. The company plays a vital role in the financial sector with its diverse offerings. Conference Call for Financial Discussion On the...

Continue Reading
VSee Health Experiences Significant Stock Surge After Approval

Updated Category News Views 271

VSee Health Inc. Stock Surges Over 45% Recently, VSee Health Inc. (NASDAQ: VSEE) experienced an impressive jump in its stock price, increasing by 45.28% to reach $1.54 during after-hours trading. This surge marks a notable uptick from its closing price of $1.06 earlier in the day, which represented a remarkable rise of 71.66% according to market data. Impact of Federal...

Continue Reading
Exciting Grand Opening for New Homes in Dacono, CO

Updated Category News Views 193

Exciting Grand Opening for New Homes in Dacono, CO Century Communities, Inc. (NYSE: CCS), a leading national homebuilder celebrated for its innovative approach to online home sales, is thrilled to unveil a Grand Opening event at Sweetgrass in Dacono. This event marks the debut of the community's stunning new model home, bringing an exciting opportunity for potential...

Continue Reading
Shakumoto Housei's Kickstarter: Artisan Neckties Unite People

Updated Category News Views 162

Shakumoto Housei's Journey to Craft Neckties with Heart In today's fast-paced world of fashion, Shakumoto Housei, a cherished small necktie manufacturer from Japan, is embarking on a unique adventure. This family-operated firm aims to connect with the global community through a heartfelt Kickstarter project. Rather than merely producing neckties, the initiative represents...

Continue Reading
Beko's Call for Sustainable Refrigeration in Food Security

Updated Category News Views 108

Refrigeration's Crucial Role in Global Food Security This year's World Food Day theme, 'Right to Foods for a Better Life and a Better Future', emphasizes the importance of worldwide access to food, highlighting the often-overlooked role of refrigeration. A recent report underscores that insufficient and unreliable refrigeration contributes significantly to food spoilage,...

Continue Reading